Antiangiogenic and anticancer molecules in cartilage

Expert Reviews in Molecular Medicine
Debabrata Patra, Linda J Sandell

Abstract

Cartilage is one of the very few naturally occurring avascular tissues where lack of angiogenesis is the guiding principle for its structure and function. This has attracted investigators who have sought to understand the biochemical basis for its avascular nature, hypothesising that it could be used in designing therapies for treating cancer and related malignancies in humans through antiangiogenic applications. Cartilage encompasses primarily a specialised extracellular matrix synthesised by chondrocytes that is both complex and unique as a result of the myriad molecules of which it is composed. Of these components, a few such as thrombospondin-1, chondromodulin-1, the type XVIII-derived endostatin, SPARC (secreted protein acidic and rich in cysteine) and the type II collagen-derived N-terminal propeptide (PIIBNP) have demonstrated antiangiogenic or antitumour properties in vitro and in vivo preclinical trials that involve several complicated mechanisms that are not completely understood. Thrombospondin-1, endostatin and the shark-cartilage-derived Neovastat preparation have also been investigated in human clinical trials to treat several different kinds of cancers, where, despite the tremendous success seen in preclinical tr...Continue Reading

References

Feb 1, 1975·The Journal of Experimental Medicine·H Brem, J Folkman
Feb 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·E W RainesE H Sage
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Jun 1, 1995·Baillière's Clinical Haematology·H R Lijnen, D Collen
May 1, 1993·Developmental Dynamics : an Official Publication of the American Association of Anatomists·M L Iruela-ArispeP Bornstein
Aug 26, 1998·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·T R KyriakidesP Bornstein
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y H DingD C Wiley
Mar 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·M A MosesR Langer
Apr 6, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·R J TresslerS Rosenberg
Apr 17, 1999·The Journal of Biological Chemistry·M DhanabalV P Sukhatme
Nov 24, 1999·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Q Yan, E H Sage
Mar 8, 2000·Journal of Molecular Biology·E HohenesterR Timpl
May 10, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·K D HankensonP Bornstein
Sep 9, 2000·Current Opinion in Cell Biology·J Lawler
Dec 5, 2000·Matrix Biology : Journal of the International Society for Matrix Biology·H ChenJ Lawler
May 5, 2001·Molecular Cell·S A KarumanchiV P Sukhatme
May 9, 2001·The Journal of Clinical Investigation·A D Bradshaw, E H Sage
May 18, 2001·Developmental Dynamics : an Official Publication of the American Association of Anatomists·O BrandauA Aszódi
Jul 14, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·M S Pepper
Jan 30, 2002·The Journal of Biological Chemistry·Jun-ichi HanaiVikas P Sukhatme
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Frank K ReiherSteven C Campbell

❮ Previous
Next ❯

Citations

Jan 21, 2014·Connective Tissue Research·Linda J Sandell
Jul 15, 2015·International Journal of Oncology·Pengfei ZhangXiaoshan Feng
Apr 29, 2014·Biomaterials·Byung Hyune ChoiByoung-Hyun Min
Apr 24, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Kiyo MondoDeborah C Mash
Sep 25, 2014·Tissue Engineering. Part a·Yueqian ZhuGuangdong Zhou
Jul 18, 2017·International Journal of Molecular Sciences·Dimitry A ChistiakovAlexander N Orekhov
Oct 27, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Peter GálKarel Smetana
Jun 2, 2015·Therapeutic Advances in Musculoskeletal Disease·Moti L Tiku, Hatem E Sabaawy
Oct 30, 2019·Artificial Organs·Do Young ParkByoung-Hyun Min
Jul 19, 2019·Cellular and Molecular Life Sciences : CMLS·Sipin ZhuJiake Xu
Jan 4, 2019·Tissue Engineering and Regenerative Medicine·Hyun Ju OhByoung-Hyun Min
Jul 4, 2020·Tissue Engineering and Regenerative Medicine·Hee-Woong YunByoung-Hyun Min
May 17, 2018·Stem Cells International·Navneet Kumar DubeyWin-Ping Deng
Feb 2, 2021·Frontiers in Pharmacology·Shao-Hsiang LiuAlan Yueh-Luen Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.